caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1558650721

Florence Chau-EtchepareMD

Pulmonary DiseaseSacramento, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
554
Unique beneficiaries
—
Total services
823
Distinct HCPCS
12
Medicare payment
$57K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 901 Pulmonary Disease providers in CA — below median (cohort median 927).
REFERRAL NETWORK

Where Florence Chau-Etchepare's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
John Livoni
Diagnostic Radiology · Rolling Hills Estates, CA
2240
Friedrich Knollmann
Diagnostic Radiology · Philadelphia, PA
1741
Cyrus Bateni
Diagnostic Radiology · Sacramento, CA
1427
Scott Evans
Diagnostic Radiology · Wheat Ridge, CO
1329
Elizabeth Moore
Diagnostic Radiology · Sacramento, CA
1219
Seth Little
Diagnostic Radiology · Jonesboro, AR
1125
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
894
Beneficiaries
—
Total drug cost
$2.8M
Distinct drugs
25
Brand share
58.8%
Top prescribed drugs
Azithromycin104 claims
Montelukast Sodium89 claims
Albuterol Sulfate87 claims
Elexacaftor/Tezacaftor/Ivacaft76 claims
Tiotropium Bromide51 claims
QUALITY · MIPS · 2024
Final MIPS score
90.1
Quality
86.2
Cost
78.4
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.64%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.